Unknown

Dataset Information

0

Positive N-Methyl-D-Aspartate Receptor Modulation by Rapastinel Promotes Rapid and Sustained Antidepressant-Like Effects.


ABSTRACT: BACKGROUND:Modulation of glutamatergic synaptic transmission by N-methyl-D-aspartate receptors can produce rapid and sustained antidepressant effects. Rapastinel (GLYX-13), initially described as a N-methyl-D-aspartate receptor partial glycine site agonist, exhibits rapid antidepressant effect in rodents without the accompanying dissociative effects of N-methyl-D-aspartate receptor antagonists. METHODS:The relationship between rapastinel's in vitro N-methyl-D-aspartate receptor pharmacology and antidepressant efficacy was determined by brain microdialysis and subsequent pharmacological characterization of therapeutic rapastinel concentrations in N-methyl-D-aspartate receptor-specific radioligand displacement, calcium mobilization, and medial prefrontal cortex electrophysiology assays. RESULTS:Brain rapastinel concentrations of 30 to 100 nM were associated with its antidepressant-like efficacy and enhancement of N-methyl-D-aspartate receptor-dependent neuronal intracellular calcium mobilization. Modulation of N-methyl-D-aspartate receptors by rapastinel was independent of D-serine concentrations, and glycine site antagonists did not block rapastinel's effect. In rat medial prefrontal cortex slices, 100 nM rapastinel increased N-methyl-D-aspartate receptor-mediated excitatory postsynaptic currents and enhanced the magnitude of long-term potentiation without any effect on miniature EPSCs or paired-pulse facilitation responses, indicating postsynaptic action of rapastinel. A critical amino acid within the NR2 subunit was identified as necessary for rapastinel's modulatory effect. CONCLUSION:Rapastinel brain concentrations associated with antidepressant-like activity directly enhance medial prefrontal cortex N-methyl-D-aspartate receptor activity and N-methyl-D-aspartate receptor-mediated synaptic plasticity in vitro. At therapeutic concentrations, rapastinel directly enhances N-methyl-D-aspartate receptor activity through a novel site independent of the glycine coagonist site. While both rapastinel and ketamine physically target N-methyl-D-aspartate receptors, the 2 molecules have opposing actions on N-methyl-D-aspartate receptors. Modest positive modulation of N-methyl-D-aspartate receptors by rapastinel represents a novel pharmacological approach to promote well-tolerated, rapid, and sustained improvements in mood disorders.

SUBMITTER: Donello JE 

PROVIDER: S-EPMC6403082 | biostudies-other | 2019 Mar

REPOSITORIES: biostudies-other

altmetric image

Publications

Positive N-Methyl-D-Aspartate Receptor Modulation by Rapastinel Promotes Rapid and Sustained Antidepressant-Like Effects.

Donello John E JE   Banerjee Pradeep P   Li Yong-Xin YX   Guo Yuan-Xing YX   Yoshitake Takashi T   Zhang Xiao-Lei XL   Miry Omid O   Kehr Jan J   Stanton Patric K PK   Gross Amanda L AL   Burgdorf Jeffery S JS   Kroes Roger A RA   Moskal Joseph R JR  

The international journal of neuropsychopharmacology 20190301 3


<h4>Background</h4>Modulation of glutamatergic synaptic transmission by N-methyl-D-aspartate receptors can produce rapid and sustained antidepressant effects. Rapastinel (GLYX-13), initially described as a N-methyl-D-aspartate receptor partial glycine site agonist, exhibits rapid antidepressant effect in rodents without the accompanying dissociative effects of N-methyl-D-aspartate receptor antagonists.<h4>Methods</h4>The relationship between rapastinel's in vitro N-methyl-D-aspartate receptor ph  ...[more]

Similar Datasets

| S-EPMC6898593 | biostudies-literature
| S-EPMC6257797 | biostudies-literature
| S-EPMC8027594 | biostudies-literature
| S-EPMC10899278 | biostudies-literature
| S-EPMC5068814 | biostudies-literature
| S-EPMC9135632 | biostudies-literature
| S-EPMC4432297 | biostudies-literature
| S-EPMC7419563 | biostudies-literature
| S-EPMC5822462 | biostudies-literature
| S-EPMC5832041 | biostudies-literature